Skip to content

CADDIE Trial - Computer Aided Diagnosis and Detection for Intelligent Endoscopy

Multi-Centre, Open-label, Randomised, Prospective Trial to Assess Efficacy and Safety of the CADDIE Artificial Intelligence System for Improving Endoscopic Detection of Colonic Polyps in Real-time.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04325815
Acronym
CADDIE
Enrollment
739
Registered
2020-03-30
Start date
2021-04-29
Completion date
2023-03-08
Last updated
2025-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma Colon, Colon Polyp, Colorectal Polyp, Polyps

Keywords

Artificial Intelligence, Endoscopy, ADR

Brief summary

Background: Colonoscopy is accepted to be the gold standard for screening of colorectal cancer (CRC). Most CRCs develop from adenomatous polyps, with colonoscopy accepted to be the gold standard for screening of CRC. An endoscopist's ability to detect polyps is assessed in the form of an Adenoma Detection Rate (ADR). Each 1.0% increase in ADR is associated with a 3.0% decrease in the risk of the patient developing an interval CRC. There remains a wide variation in endoscopist ADR. More recently, the use of artificial intelligence (AI) and computer aided diagnosis in endoscopy has been gaining increasing attention for its role in automated lesion detection and characterisation. AI can potentially improve ADR, but previous AI related work has largely focused on retrospectively assessing still endoscopic images and selected video sequences which may be subject to bias and lack clinical utility. There are only limited clinical studies evaluating the effect of AI in improving ADR. The CADDIE device uses convolutional neural networks developed for computer assisted detection and computer assisted diagnosis of polyps. Primary objective: To determine whether the CADDIE artificial intelligence system improves endoscopic detection of adenomas during colonoscopy. Primary endpoint: The difference in adenoma detection rate (ADR) between the intervention (supported with the CADDIE system) and non-intervention arm Study design: Multi-Centre, open-label, randomised, prospective trial to assess efficacy and safety of the CADDIE artificial intelligence system for improving endoscopic detection of colonic polyps in real-time.

Interventions

DEVICECADDIE- Computer Aided (AI) Device used in Endoscopy

1. CADDIE assisted polyp detection 2. CADDIE assisted polyp characterisation

Sponsors

University College, London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient's scheduled to undergo a surveillance or symptomatic colonoscopy with an endoscopist participating in the study phase of the trial. * Male and female participants aged 18 years or older at the time of informed consent. * Patient's able to comprehend, sign and date the written informed consent document to participate in the study.

Exclusion criteria

* Emergency colonoscopies and/or inpatient colonoscopies. * Patients with inflammatory bowel disease (IBD) * Patients with Colorectal Cancer (CRC) * Patients with previous CRC * Patients with previous colonic resection * Patients returning for a planned elective therapeutic colonoscopy. * Polyposis syndromes * Current or relevant history of a physical or psychiatric illness or any medical condition that in the opinion of the investigator could affect the patient's safety or interfere with the study assessments * Patients with a contraindication for biopsy or polypectomy. These include: * Patients who have not withheld medications pre-disposing to bleeding at time of colonoscopy as per local site /national guidelines 30. * Patients with a history of haemostasis disorders (Haemostasis disorders will include but will not be limited to: patients with haemophilia or other congenitally acquired clotting factor deficiencies, patients with cirrhosis with coagulopathy, patients known to have thrombocytopenia (\<80,000 platelet/ul) and individuals with Von Willebrand's disease or other known platelet malfunction disorders). * Patients is enrolled in another research study with an investigational medicinal product (IMP) or non-IMP that pre-disposes them to bleeding

Design outcomes

Primary

MeasureTime frameDescription
To Evaluate Whether Using the CADDIE System Improves Endoscopist Detection of Adenomas During Colonoscopy.30 daysThe difference in endoscopist ADR between the intervention (CADDIE system) and non-intervention arm.

Secondary

MeasureTime frameDescription
To Determine Whether the CADDIE Artificial Intelligence System Improves Endoscopic Detection of All Polyps During Colonoscopy30 daysPolyp Detection Rate (including proximal polyp detection rate) in the interventional group compared to the control group. \- Mean number of polyps detected per colonoscopy in the interventional group compared to the control group.
Compare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)30 daysCompare the accuracy of CADDIE against human endoscopist (high confidence diagnoses) for the optical diagnosis of diminutive polyps. Accuracy is defined as true positive and true negative divided by diagnoses total polyps that were optically diagnosed with high confidence.
Compare the Accuracy of Endoscopist Optical Diagnosis to Assign Colonoscopy Surveillance Intervals When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)30 daysCompare the accuracy of using CADDIE's optical diagnosis to assign surveillance colonoscopy intervals against using human endoscopist optical diagnosis (high confidence diagnoses) for assigning surveillance colonoscopy intervals.
Evaluate the Difference in Number of Adenomas Detected Per Colonoscopy Between Intervention and Non-intervention Arm30 daysCompare the difference in the number of adenomas detected per colonoscopy between the intervention and non-intervention arm
Evaluate the Safety of the CADDIE by Recording Occurrence and Severity of Adverse Events.30 daysSafety of the device will be assessed through monitoring of adverse events for 30 days' post-procedure. Adverse events are defined as: * Abdominal pain/discomfort. * Abdominal bloating. * Sedation related aspiration. * Bleeding risk. * Perforation. * Post polypectomy electrocoagulation syndrome. * Infection.
Assess Patient Anxiety During the Colonoscopy30 daysPatient response to the question 'How anxious or calm were you during the colonoscopy?' assessed by Likert Scale with 5 options - 1 (Very anxious), 2 (Somewhat anxious), 3 (Neither Anxious nor calm), 4 (Somewhat calm), 5 (Very calm).
Compare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Rectal Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)30 daysCompare the accuracy of CADDIE against human endoscopist (high confidence diagnoses) for the optical diagnosis of diminutive rectal polyps.

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
CADDIE
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function. CADDIE- Computer Aided (AI) Device used in Endoscopy: 1. CADDIE assisted polyp detection 2. CADDIE assisted polyp characterisation
306
Standard Procedure
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
309
Total615

Baseline characteristics

CharacteristicCADDIEStandard ProcedureTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
130 Participants108 Participants238 Participants
Age, Categorical
Between 18 and 65 years
176 Participants201 Participants377 Participants
Age, Continuous59.4 years
STANDARD_DEVIATION 14.7
58.0 years
STANDARD_DEVIATION 14.8
58.7 years
STANDARD_DEVIATION 14.7
Race/Ethnicity, Customized
Ethnicity/Race
Arab
5 Participants6 Participants11 Participants
Race/Ethnicity, Customized
Ethnicity/Race
Asian Chinese
3 Participants2 Participants5 Participants
Race/Ethnicity, Customized
Ethnicity/Race
Asian Other
6 Participants3 Participants9 Participants
Race/Ethnicity, Customized
Ethnicity/Race
Black
4 Participants11 Participants15 Participants
Race/Ethnicity, Customized
Ethnicity/Race
Jewish
1 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Ethnicity/Race
Mixed race
3 Participants2 Participants5 Participants
Race/Ethnicity, Customized
Ethnicity/Race
Other
13 Participants10 Participants23 Participants
Race/Ethnicity, Customized
Ethnicity/Race
South East Asian
24 Participants11 Participants35 Participants
Race/Ethnicity, Customized
Ethnicity/Race
White British/Irish
226 Participants247 Participants473 Participants
Race/Ethnicity, Customized
Ethnicity/Race
White European
21 Participants16 Participants37 Participants
Region of Enrollment
United Kingdom
306 participants309 participants615 participants
Sex: Female, Male
Female
159 Participants156 Participants315 Participants
Sex: Female, Male
Male
147 Participants153 Participants300 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 3680 / 371
other
Total, other adverse events
10 / 36813 / 371
serious
Total, serious adverse events
5 / 3681 / 371

Outcome results

Primary

To Evaluate Whether Using the CADDIE System Improves Endoscopist Detection of Adenomas During Colonoscopy.

The difference in endoscopist ADR between the intervention (CADDIE system) and non-intervention arm.

Time frame: 30 days

ArmMeasureValue (NUMBER)
CADDIETo Evaluate Whether Using the CADDIE System Improves Endoscopist Detection of Adenomas During Colonoscopy.33.30 ADR (% of participants)
Standard ProcedureTo Evaluate Whether Using the CADDIE System Improves Endoscopist Detection of Adenomas During Colonoscopy.25.20 ADR (% of participants)
Secondary

Assess Patient Anxiety During the Colonoscopy

Patient response to the question 'How anxious or calm were you during the colonoscopy?' assessed by Likert Scale with 5 options - 1 (Very anxious), 2 (Somewhat anxious), 3 (Neither Anxious nor calm), 4 (Somewhat calm), 5 (Very calm).

Time frame: 30 days

ArmMeasureValue (MEAN)Dispersion
CADDIEAssess Patient Anxiety During the Colonoscopy2.989 score on a scaleStandard Deviation 1.193
Standard ProcedureAssess Patient Anxiety During the Colonoscopy3.061 score on a scaleStandard Deviation 1.241
Secondary

Compare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)

Compare the accuracy of CADDIE against human endoscopist (high confidence diagnoses) for the optical diagnosis of diminutive polyps. Accuracy is defined as true positive and true negative divided by diagnoses total polyps that were optically diagnosed with high confidence.

Time frame: 30 days

ArmMeasureValue (NUMBER)
CADDIECompare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)87.5 % of adenomas correctly diagnosed
Standard ProcedureCompare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)76.7 % of adenomas correctly diagnosed
Secondary

Compare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Rectal Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)

Compare the accuracy of CADDIE against human endoscopist (high confidence diagnoses) for the optical diagnosis of diminutive rectal polyps.

Time frame: 30 days

ArmMeasureValue (NUMBER)
CADDIECompare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Rectal Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)73.3 % of adenomas correctly diagnosed
Standard ProcedureCompare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Rectal Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)53.3 % of adenomas correctly diagnosed
Secondary

Compare the Accuracy of Endoscopist Optical Diagnosis to Assign Colonoscopy Surveillance Intervals When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)

Compare the accuracy of using CADDIE's optical diagnosis to assign surveillance colonoscopy intervals against using human endoscopist optical diagnosis (high confidence diagnoses) for assigning surveillance colonoscopy intervals.

Time frame: 30 days

ArmMeasureValue (NUMBER)
CADDIECompare the Accuracy of Endoscopist Optical Diagnosis to Assign Colonoscopy Surveillance Intervals When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)90.9 % pts with correct surveillance interval
Standard ProcedureCompare the Accuracy of Endoscopist Optical Diagnosis to Assign Colonoscopy Surveillance Intervals When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)87.2 % pts with correct surveillance interval
Secondary

Evaluate the Difference in Number of Adenomas Detected Per Colonoscopy Between Intervention and Non-intervention Arm

Compare the difference in the number of adenomas detected per colonoscopy between the intervention and non-intervention arm

Time frame: 30 days

ArmMeasureValue (MEAN)Dispersion
CADDIEEvaluate the Difference in Number of Adenomas Detected Per Colonoscopy Between Intervention and Non-intervention Arm0.66 Adenomas per colonoscopyStandard Deviation 1.44
Standard ProcedureEvaluate the Difference in Number of Adenomas Detected Per Colonoscopy Between Intervention and Non-intervention Arm0.42 Adenomas per colonoscopyStandard Deviation 0.98
Secondary

Evaluate the Safety of the CADDIE by Recording Occurrence and Severity of Adverse Events.

Safety of the device will be assessed through monitoring of adverse events for 30 days' post-procedure. Adverse events are defined as: * Abdominal pain/discomfort. * Abdominal bloating. * Sedation related aspiration. * Bleeding risk. * Perforation. * Post polypectomy electrocoagulation syndrome. * Infection.

Time frame: 30 days

ArmMeasureValue (NUMBER)
CADDIEEvaluate the Safety of the CADDIE by Recording Occurrence and Severity of Adverse Events.15 AE/SAE
Standard ProcedureEvaluate the Safety of the CADDIE by Recording Occurrence and Severity of Adverse Events.14 AE/SAE
Secondary

To Determine Whether the CADDIE Artificial Intelligence System Improves Endoscopic Detection of All Polyps During Colonoscopy

Polyp Detection Rate (including proximal polyp detection rate) in the interventional group compared to the control group. \- Mean number of polyps detected per colonoscopy in the interventional group compared to the control group.

Time frame: 30 days

ArmMeasureValue (MEAN)Dispersion
CADDIETo Determine Whether the CADDIE Artificial Intelligence System Improves Endoscopic Detection of All Polyps During Colonoscopy0.87 PPCStandard Deviation 1.59
Standard ProcedureTo Determine Whether the CADDIE Artificial Intelligence System Improves Endoscopic Detection of All Polyps During Colonoscopy0.63 PPCStandard Deviation 1.24

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026